TickerFacts.

Carlsmed, Inc. (CARL): Capital Expenditures

Annual figures by period end, from SEC filings.

$642.0K
Year ended 2025-12-31
$432.0K
Trailing 12 months to 2026-06-30
2024-12-31: $180.0K2025-12-31: $642.0K$642.0K
2024-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$642.0K+256.7%2026-02-25, From 2025-01-01
2024-12-31$180.0Kn/a2026-02-25, From 2024-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Carlsmed, Inc. (CARL)2025-12-31$642.0K+256.7%
Apyx Medical Corp (APYX)2025-12-31$1.11M+54.3%
Shoulder Innovations, Inc. (SI)2025-12-31$7.41M+84.5%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$918.0K+166.1%
CVRx, Inc. (CVRX)2025-12-31$580.0K-57.4%
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.94M+296.3%
LENSAR, Inc. (LNSR)2025-12-31$83.0K-46.8%
SS Innovations International, Inc. (SSII)2025-12-31$3.66M+453.2%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$15.6K-88.3%

Compare CARL, APYX, SI, TLSI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗